维护β细胞作为糖尿病治疗策略
Jalal Taneera1,2, Maha M Saber-Ayad1,2
1College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
概括
保护胰腺小岛β细胞对于管理1型和2型糖尿病至关重要. 针对β细胞功能,质量和生存的疗法为改善血糖控制提供了有希望的途径.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 代谢性疾病 代谢性疾病
背景情况:
- 胰腺小岛β细胞的保存对于1型 (T1D) 和2型糖尿病 (T2D) 的管理至关重要.
- 贝塔细胞功能障碍,质量减少和亡导致两种糖尿病类型的胰岛素分泌不足.
- 了解β细胞调节是开发新疗法策略的关键.
研究的目的:
- 审查目前关于在糖尿病中保护胰腺小岛β细胞的研究.
- 探索T1D和T2D的治疗方法,重点关注β细胞的保护和再生.
主要方法:
- 对T1D和T2D管理策略的现有文献的审查.
- 治疗干预措施的分析,包括免疫抑制,抗炎药物,干细胞治疗,生活方式修改,药理学药物和减肥手术.
主要成果:
- 治疗T1D的重点是免疫抑制和细胞替代 (小岛,干细胞,异种移植).
- 二型糖尿病的管理包括生活方式的改变,药理学药物针对炎症和葡萄糖毒性,以及减肥手术.
- 腹部外科手术通过改善β细胞功能,胰岛素敏感性和质量,对T2D显示出显著的益处.
结论:
- 维护β细胞是T1D和T2D的有希望的策略.
- 改变生活方式,向药理学和先进疗法的结合可以增强β细胞功能和葡萄糖调节.
相关概念视频
Insulin: Biosynthesis, Chemistry, and Preparation
377
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
377
Tissue Renewal without Stem Cells
1.7K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.7K
Diabetes: Management and Pharmacotherapy
283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K


